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Abstract: Brucellosis is a global zoonosis caused by Gram-negative, facultative intracellular bacteria of
the genus Brucella (B.). Proteomics has been used to investigate a few B. melitensis and B. abortus strains,
but data for other species and biovars are limited. Hence, a comprehensive analysis of proteomes will
significantly contribute to understanding the enigmatic biology of brucellae. For direct identification
and typing of Brucella, matrix-assisted laser desorption ionization—time of flight mass spectrometry
(MALDI—TOF MS) has become a reliable tool for routine diagnosis due to its ease of handling, price
and sensitivity highlighting the potential of proteome-based techniques. Proteome analysis will also
help to overcome the historic but still notorious Brucella obstacles of infection medicine, the lack of
safe and protective vaccines and sensitive serologic diagnostic tools by identifying the most efficient
protein antigens. This perspective summarizes past and recent developments in Brucella proteomics
with a focus on species identification and serodiagnosis. Future applications of proteomics in these
fields are discussed.
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1. Introduction
Brucellosis is one of the most frequent bacterial zoonoses spread worldwide. The infection is
most often acquired via the consumption of unpasteurized milk and dairy products or direct or
indirect contact with infected animals or their excretes [1]. The main symptom in animals is abortion,
and consequently, the disease was named infectious abortion, contagious abortion, enzootic abortion
or Bang’s disease. In humans, the cardinal symptom is fever resulting in names like Crimean fever,
Mediterranean fever, rock fever, undulant fever or Malta fever. Finally, the term ‘brucellosis’ was
established to clarify the etiology of a manifold syndrome. To date, the genus Brucella (B.) encompasses
12 accepted nomo-species. The classical six species are B. abortus, B. melitensis, B. suis, B. canis, B. ovis
and B. neotomae, which were primarily isolated from bovines, small ruminants, pigs, dogs, sheep and
desert woodrats, respectively [2]. Two species of marine origin, B. pinnipedialis and B. ceti, were isolated
from aquatic mammals [3]. B. inopinata [4] and B. microti [5] were gained from samples of a breast
implant and common voles, respectively. B. papionis was described as eleventh species isolated from
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baboons (Papio spp.) [6], and recently, B. vulpis was isolated from the mandibular lymph nodes of red
foxes (Vulpes vulpes) [7].
Brucellae are Gram-negative facultative intracellular stealthy pathogens. They can escape
recognition of the innate immunity and avoid the intracellular destruction [8]. The virulence and
pathogenesis of Brucella spp. are mainly associated with their survival and replication inside the host
cells, including phagocytic and non-phagocytic cells. Brucellae are closely related, share noticeable
similar genomes, but differ in their natural hosts, phenotypes as well as their immunogenic, proteomic
and metabolomic properties [9,10]. To date, the mechanism behind host specificity is enigmatic.
Host specificity might be caused by species-specific gene inactivation/activation that influences
transcriptional regulators and outer membrane proteins [11]. Brucella lacks classical virulence factors
and several aspects of its biology e.g., pathogenesis, survival in macrophages, and host specificity, are
still not well understood. To explain its virulence and host specificity, a better understanding at the
proteome and metabolome level could be helpful [12].
Currently, no safe human vaccine exists, while animal immunization is usually accomplished
using live attenuated strains, such as B. abortus RB51 and S19, as well as B. melitensis Rev.1 [13]. Live
attenuated vaccines have several drawbacks in animals such as residual virulence, abortion and
interference with serology, and they are pathogenic for humans. In the last decade, various types
of subunit vaccine candidates utilizing proteomic technology have been proposed. However, some
problems regarding the levels of protection and safety remain a matter of open discussion [14].
The diagnosis of brucellosis remains challenging and is based mainly on the serology and
isolation of Brucella. Serology basically relies on the detection of anti-Brucella lipopolysaccharide
(LPS) antibodies. LPS-based assays have a low specificity due to cross-reactions resulting from
the similarity between immunodominant epitopes of Brucella O-polysaccharide and those of other
Gram-negative bacteria resulting in a false-positive reaction. Indeed, serology based on the use of a
LPS antigen does not allow the discrimination of vaccinated and infected animals. This fact raised the
need to replace the LPS antigen by protein antigens. The identification of genus- or species-specific
protein candidates would be useful in designing diagnostics tools, which could diagnose Brucella
infection and differentiate between infections caused by different Brucella species, respectively [15].
A comprehensive understanding of the intricate relation between the host cell and brucellae will
improve the development of species-specific treatment and the design of better diagnostic tools and
vaccines. The detection of prominent immunogenic proteins during the course of infection can help in
the development of advanced diagnostic tools with high specificity and accuracy [16].
Proteomic technologies are major post-genomic approaches used to understand the consequences
of regulatory processes on the protein composition of microbes. They have proven to be efficient
tools to study the microbial physiology, gene expression and the interaction between the bacteria
and the host cells [17,18]. The application of qualitative proteomics analysis has contributed to rapid
species identification. A quantitative proteomic technique based on both gel and mass spectrometry
approaches has been applied for a better understanding of the various aspects of the life cycle of the
organisms. It has also aided in unraveling several enigmatic aspects of Brucella biology i.e., host-cell
interaction, stress response, antibiotic targets and protein secretion [19], as well as the development of
subunit vaccines and the identification of antigens for diagnosis. Here, we reviewed proteomic studies
that have been carried out in brucellae with a focus on rapid species identification and improvement
of serodiagnostics.
2. Rapid Species Identification of Brucella Using Matrix-Assisted Laser Desorption
Ionization—Time of Flight Mass Spectrometry (MALDI—TOF MS)
The regular diagnosis of brucellosis relies on the indirect detection of anti-Brucella antibodies in
milk by the milk ring test (MRT) as a field test, or by serological tools such as the slow agglutination test
(SAT) and the rose bengal test (RBT), which are confirmed by the complement fixation test (CFT) and the
enzyme-linked immunosorbent assay (ELISA) [20]. One of the main diagnostic challenges in serology
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is the cross-reaction resulting from the similarity of the O-antigenic side chain of LPS of Brucella to other
Gram-negative bacteria. Thus, the diagnosis of Brucella based on sero-reactors should be handled with
extreme caution unless accompanied by bacteriological and molecular diagnosis. Isolation, the classical
biotyping and identification of Brucella spp., remains the gold standard for diagnosis, but it is hazardous,
laborious, time-consuming and requires well trained personnel [21]. The genus-level identification
relies on the classical bacteriological analysis of cultured colonies and DNA-based molecular tools [22].
The characterization of Brucella at the species and biovars level requires complete bacteriological and
biochemical testing or advanced molecular techniques e.g., AMOS-PCR (an abortus, melitensis, ovis
and suis-PCR) [23], multiplex PCR assay (Bruce-ladder) [24], multiple-locus variable number tandem
repeat analysis (MLVA) [25], and whole genome sequencing (WGS) technology [26]. Both bacteriology
and molecular assays require expertise, are time-consuming and laborious. Besides, the resolution of
band sizes restricts existing PCR assays used for the detection of Brucella species on a gel [27].
In the past two decades, matrix-assisted laser desorption ionization—time of flight mass spectrometry
(MALDI—TOF MS)-based typing, intact protein profiling (IPP) or intact-cell mass spectrometry (ICMS)
have emerged as rapid species identification methods in the routine diagnostic laboratories [28–35].
In this method, a crude microbial sample is directly transferred on to the MALDI target plate, overlaid
with UV-absorbing matrix solution, dried, the spectra is measured in a broad m/z range (2000–20,000 kDa)
and the species identification is performed by pattern-matching with the database of reference spectra of
known microorganisms [36]. The accuracy of the method is dependent on the availability of high-quality
reference spectra, which is usually created using the most reproducible peaks (usually 70 peaks in the
range of 2000–20,000 m/z) of high abundant proteins and ribosomal proteins specific to the species [37].
As mentioned, there is a minimal or no sample preparation step involved as culture colonies are directly
transferred, proven rapidness (2–5 min from culture plate to species identification), the comparable
accuracy to that of molecular methods and the high-throughput analysis and high-level occupational
safety. Brucellae are identified by comparing the obtained MS spectra from each isolate to the reference
spectra from a reference library [32]. For Brucella, taxon-specific mass spectral databases and peak pattern
matching software tools are available now but additional reference spectra data on biovars are required
to be created. Among several commercial software tools, the database integrated into the VITEK MS
of the BioMerieuxbecame the first Brucella database validated for diagnostics with accreditation and
is accessible to all users in routine diagnosis in 2010. A MALDI Biotyper (Bruker) was used to create
reference spectra databases for B. melitensis, B. abortus, B. suis, B. canis, B. ceti and B. pinnipedialis [34].
The accuracy and stability of the technique were re-evaluated by testing a comprehensive collection of
field and reference strains of well known Brucella spp. including B. abortus, B. melitensis, B. suis, B. canis,
B. ceti, B. inopinata, B. microti, B. ovis, B. pinnipedialis and B. neotomae [31]. At the species level, 99.3% of 152
and 92% of 104 isolates were correctly identified. Misidentifications for B. abortus, B. melitensis, B. suis and
B. ceti were reported to be very low, while incorrect biovar assignments were found frequently except for
B. suis [31,32]. Constructing a reference library based on genetic relationships according to MLVA data
improved the accurate identification of Brucella species with MALDI—TOF MS [32].
The difference in peak intensities due to growth conditions of the bacteria or the values of protein
concentration was reported to be the least influential on species identification as the MALDI—TOF
MS software tools considered only the most reproducible peaks of the generated spectra. Further
improvements in terms of protein extraction protocols and the creation of unique brucellae reference
databases have been reported [38]. In a recent study, a MALDI—TOF MS reference database was
created and reported to identify the main classical human pathogens B. melitensis, B. abortus and B. suis
at the species level with an accuracy of 100%, 92.9% and 100%, respectively [39].
As shown in Table 1, several reference databases have been created including a significant amount
of type and field strains to enhance the accuracy of identification. The techniques and procedures are
cost-effective after the initial investment on the instrumentation and the software. Hence, the reliability
of the identification is based on the content and quality of the library, as well as other factors such as
the protocol used for the preparation of the samples and the extraction of the proteins, the purity of
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colonies and culture conditions. MALDI—TOF MS was successfully applied to identify brucellae at
the species level with cutoff values as per the recommendations of the software providers. However, it
is still unable to identify the various biovars. The greatest drawback of MALDI—TOF MS was the
requirement of pure colonies, which requires cultivation. Consequently, it is not a tool suitable to
detect only a few bacteria usually present in clinical samples such as cerebrospinal fluids, serum or
contaminated culture.
Recently, a liquid chromatography-tandem mass spectrometry (LC—MS/MS)-based method has
been developed as a safe, highly accurate and unprejudiced identification method to identify highly
pathogenic bacteria including Brucella [40]. This tool is based on analyzing the proteome and enables
the rapid identification of B. abortus, B. melitensis and B. suis directly from positive blood culture flasks.
The developed LC—MS/MS-based method makes use of discriminatory peptides. It considerably
reduced the time required to identify the causative agents of bacteremia, and can quickly confirm the
diagnoses of pathogens with a high level of accuracy.
Table 1. List of studies utilizing matrix-assisted laser desorption ionization—time of flight mass spectrometry
(MALDI—TOF MS) for the direct identification of brucellae.
No. Year Brucella spp. Used in Each Study No. of Strains Aim of the Study Study
1 2020 B. abortus, B. melitensis, B. suis 3, 4 and 3 Diagnosis [40]
2 2019 B. abortus, B. melitensis 29 Diagnosis [41]
3 2019 B. abortus 5 Diagnosis [42]
4 2018 B. abortus, B. melitensis, B. suis, B. canis,B. canis, B. ovis, B. neotomae 75 Database creation [38]
5 2018
B. abortus, B. melitensis, B. suis, B. canis,
B. ceti, B. inopinata, B. microti, B. ovis,
B. pinnipedialis, and B. neotomae,
B. papionis
84 Database creation [39]
6 2017 B. canis 38 Diagnosis [43]
7 2016 B. melitensis Rev-1 and B. abortus 19BA 2 Comparativeanalysis [44]
8 2016
B. abortus, B. melitensis, B. suis, B. canis,
B. neotomae, B. inopinata, B. microti,
B. ceti, B. ovis, B. pinnipedialis, and
B. papionis
15 reference strains Protocol for samplepreparation [45]
9 2015 B. canis 1 Case diagnosis [28]
10 2015 B. melitensis and B. suis 19 Diagnosis [29]
11 2013
B. abortus, B. melitensis, B. suis, B. canis,
B. ceti, B. inopinata, B. microti, B. ovis,
B. pinnipedialis, and B. neotomae




12 2013 B. melitensis and B. suis 6 and 3 Diagnosis [46]
13 2012 B. melitensis 1 Samplepreparation [30]
14 2011
B. abortus, B. melitensis, B. suis, B. canis,
B. ceti, B. neotomae, B. ovis and
B. pinnipedialis
170 Diagnosis,Database creation [32]
15 2011 B. melitensis 1 Case diagnosis [33]
16 2010 B. abortus, B. melitensis, B. suis, B. canis,B. ceti, B. pinnipedialis 131
Generating
reference spectra [34]
17 2010 B. melitensis 1 Case diagnosis [35]
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3. Gel-Based Quantitative Brucella Proteomics Analysis
Proteomics analysis using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE),
two-dimensional gel electrophoresis (2DE), difference gel electrophoresis (DIGE) and MALDI—TOF
MS remains the gold standard for protein separation and the quantification of proteins from various
samples. At the end of the 20th century, SDS-PAGE profiles (protein separation based on molecular
weight) and immunoblotting were used in early studies of Brucella taxonomy [47], and to describe
various proteomes of different Brucella species [48–54]. The initial idea was to isolate and characterize
the outer membrane proteins of B. abortus and to compare those proteins with those of other vaccines
and virulent strains [48,49]. Comparative analyses of outer membrane proteins extracted from the
field strains of B. ovis and B. melitensis were investigated to identify an effective subcellular vaccine
for ovine brucellosis [51]. Even though the SDS-PAGE proved that each species has a specific protein
band pattern, the identification of a single protein was nearly impossible as each band was composed
of several proteins of the same molecular weight (Figure 1). The technological improvement led to
two-dimensional electrophoresis—Western blotting (2DE—WB) and mass spectrometry for protein
identification. Two-dimensional electrophoresis—Western blotting has the ability to separate and
display thousands of single proteins [55]. This technique provided much information about the proteins
of complex samples. In the 2DE, proteins are separated based on their net charge and their molecular
weight, and proteins are resolved as spots spread down in the gel. Those spots are representing various
individual proteins (Figure 1). The combination of one- and two-dimensional gel electrophoresis and
cellular immunoblotting were applied to improve protein identification and to compare the similarities
of protein profiles among different Brucella spp. [52]. Two-dimensional electrophoresis—Western
blotting, in combination with protein microsequencing, was used to map B. melitensis proteins.
Comparative studies of protein expression for other brucellae followed [56,57]. Subsequently, this
technology was used to study the pathogenesis of Brucella and to investigate its intracellular survival
and its resistance strategy within macrophages [58]. To identify virulence-associated proteins in
B. abortus, whole proteomes of virulent and of S19 vaccine strains were compared [59]. At the beginning
of the 21st century, peptide mass fingerprinting, which employs MALDI—TOF MS, was applied to
identify proteins that resulted in the rapid and large-scale mapping of whole brucellae proteomes.
The mapping of complete Brucella proteomes, comparative proteomic analysis between different
Brucella spp. (virulent and vaccine strains), and the examination of the differences in the protein
profiles of Brucella grown under different conditions was investigated in a broad spectrum and on a
large scale [45–47].
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Figure 1. SDS-PAGE and two-dimensional gel electrophoresis (2DE)-stained gel with Coomassie
prepared at our laboratory, each well containing 10 µg of proteins of B. abortus and B. melitensis, while
each 2DE gel contains 150 µg of acetone-precipitated cell lysate of B. abortus and B. melitensis and
showing the levels of various individual proteins.
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To date, our understanding of the Brucella proteome is limited. Differences at the proteomic
level of brucellae have been investigated with different growth conditions like temperature or acidity,
and oxidative or nutritional stress [60]. In 1997, the mapping of B. melitensis B115 proteins was done
using 2DE. The 2DE proteins map revealed 595 silver-stained protein spots and was considered the basis
for comparative studies of protein expression in Brucella at that time [56]. The fast technical progress
in the use of proteomics started in the early 2000s (Figure 2). For instance, a comparative proteomic
analysis of a B. melitensis strain 16 M was done to identify and characterize the proteins expressed under
laboratory conditions. Two-dimensional gel electrophoresis was used for protein separation. Of the
883 observed protein spots, 440 were identified by MALDI—TOF MS in a laboratory-grown culture.
The consideration of the proteomic data with genomic sequences should lead to the identification of
biochemical pathways associated with host specificity, pathogenicity, stress responses and virulence.
The protein list of that study became the 2DE protein map to serve as a reference for subsequent Brucella
proteomic studies [61]. Subsequently, the protein mapping of B. melitensis 16M was done to highlight
the differences in protein expression with the attenuated B. melitensis Rev.1 vaccine strain. Certain
metabolic pathways as well as the up and down-regulation of protein expression specific to each strain
were studied, e.g., the differences in the expression of immunogenic 31-kDa outer membrane protein
in Rev. 1 strain. This protein plays a role in sugar and amino acid binding, iron acquisition and lipid
degradation [62,63]. Quantitative and qualitative differences in the protein expression patterns between
two well-known human pathogens, B. melitensis and B. abortus, were studied by 2DE and peptide mass
fingerprinting via MALDI—TOF MS using laboratory-grown reference strains B. melitensis 16M and
B. abortus 2308 [64]. To understand the mechanism of B. abortus infection, the proteins secreted into the
cultural supernatant were studied under laboratory conditions. More than 27 soluble immunogenic
proteins were detected by 2DE and mass spectrometry. Those proteins induced strong humoral and
cell-mediated immune responses and could promote antibody production leading to enhanced host
defense against subsequent bacterial infection [65]. DIGE allowed the quantitative characterization of
the intramacrophagic proteome and had sufficient discriminatory power to identify B. suis and host
cell proteins connected to infection [66]. This approach helped to quantify the intracellular proteomes
of different pathogens in a specific host cell. Around 168 proteins were altered in comparison to the
extracellularly grown bacteria, and 44 proteins involved in bacterial metabolism were significantly
regulated at the late stage of infection. A comparative proteome analysis of B. abortus 2308 and its virB
type IV secretion system mutant using 2DE and mass spectrometry helped to identify new T4SS-related
candidate proteins [67]. To investigate the regulative processes of B. suis survival under extreme
nutrient starvation, DIGE provided a quantitative analysis of proteomes after long-term nutrient
starvation of B. suis [68]. Thirty proteins were regulated in comparison to the bacteria grown in a rich
medium and 70% of proteins involved in the adaptation to harsh conditions, transport and regulation
showed over expression.
Proteomics analysis using 2DE and MALDI—TOF MS revealed that the changes in protein
abundance of the infected host cells appeared between 48 and 96 h post-infection [69]. In recent years,
attempts were made to better understand host-microbe interactions. The 2DE and mass spectrometry
were used to identify proteins in the lung tissue of BALB/c mice challenged by aerosolized B. melitensis
bacteria. Twelve differentially expressed proteins were involved in the infectious process of lung
tissue [70]. In contrast to the SDS-PAGE, in the 2DE, the proteins could be separated, and the spots
could be quantified and analyzed by MS, but the technique has a limited dynamic range. It is difficult
to separate the low abundant proteins or very large proteins, and the technique requires a large amount
of sample. Moreover, due to the staining sensitivity, some protein spots are difficult to visualize,
and only Coomassie staining can be easily removed easily from the gel for further identification by MS.
Thus, the attempts to use gel-free tools followed.
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Figure 2. Chronological application of proteomics technology in Brucella research. SDS-PAGE
(sodium dodecyl sulfate-polyacrylamide gel electrophoresis), 2DE (two-dimensional gel electrophoresis),
DIGE (difference gel electrophoresis), SELDI-MS (Surface-enhanced laser desorption/ionization- mass
spectrometry), MALDI-MS (matrix-assisted laser desorption/ionization—mass spectrometry) and
LC-MS (Liquid chromatography–mass spectrometry).
4. Mass Spectrometry Based Quantitative Brucella Proteomics
Proteomic analyses of variou strains of Brucella using gel-based to ls have b en reported,
suffering from limitations in terms of technology and the low number of identified proteins. Recently,
a comparative proteomic analysis was carried out sing LC—MS based on peptide fingerprinting [15].
A significant amount of data is now available to study the differences between the strains that are
associated with virulence. Multidimensional scaling of differentially expressed peptides of B. abortus
2308 and S19 during intracellular infection was analyzed by LC—MS. The results provided insights into
mechanisms utilized by brucellae to establish intracellular infection [71]. The label-free quantitative
proteomic analysis of B. abortus and B. melitensis outbreak strains from a cow and a sheep, respectively,
revealed 402 differentially expressed proteins. Among them, 63 and 103 proteins were detected
exclusively in the whole-cell extracts of B. abortus and B. melitensis, respectively [15]. The mass
spectrometry-based label-free relative quantitative proteo ics analysis of B. abortus was reported
to have identified a total of 1221 differentially expressed proteins following multiple environmental
stresses and adaptations [72]. Furthermore, the proteogenomic mapping of B. abortus 104 M human
vaccine strains using high-resolution mass spectrometry revealed 1729 proteins and 218 hypothetical
proteins [73]. The liquid chromatography/tandem mass spectrometry was used to analyze secretory
proteins from the Brucella rough mutants ∆rfbE and ∆rfbE∆virB123. In this study, 861 unique proteins
were identified, among which 37 were differential secretory proteins [74]. The proteomic analysis of
membrane blebs of B. abortus 2308 and RB51 using liquid chromatography—tandem mass spectrometry
(LC—MS/MS) succeeded to identify 220 and 171 proteins, respectively [75]. LC—MS requires skilled
personnel to set th system, and it is n expen ive optio , both i terms of the price of he unit and
the running cost . However, if th instrument is present and after trai ing, it is relatively easy to
operate daily, it offers several advantages such s improved accuracy and precision, retrieves an
important amount of information from samples in a short time and has a higher selectivity. Liquid
chromatography coupled to a tandem mass spectrometry (LC—MS/MS) has recently become a more
popular alternative for the quantitative pan-proteome analysis of Brucella [12].
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5. Serological Proteome Analysis (SERPA)
Despite the high genomic similarity among Brucella species [76], it has been demonstrated that
they evoke different immune responses in natural hosts and display different protein expression
profiles [15,77,78]. The identification of immunodominant proteins from brucellae was the target
of several studies in recent years (Table 2). Looking for such proteins is required to increase the
specificity of serodiagnostics and the development of safe subunit vaccines. Most of the studies on
Brucella immunoproteomics have focused on the use of reference strains and experimentally produced
hyper-immune sera [79–83]. However, using fully virulent field strains in proteomic studies is rarely
done [15,78]. As shown in Table 2, using different protein lysates and different anti-Brucella sera
revealed different spectra of immunoreactive proteins. When a protein sample of B. melitensis B115
was tested using monoclonal antibodies (MAbs), 25 protein spots out of 595 spots separated on a
2DE plot were stained [56]. The protein spots were identified as 89 kDa outer membrane protein,
bacterioferritin, DnaK, CP24 and BP26. The same group tested protein preparations from B. ovis with a
serum of a sheep naturally infected with B. ovis. The combination of 2DE and protein microsequencing
succeeded to identify 82 immunoreactive cytoplasmic, periplasmic and membrane protein spots [57].
When the B. abortus 1119-3 whole-cell lysate was tested with rabbit hyperimmune sera, 17 out of 383
protein spots were stained. Using the surface-enhanced laser desorption/ionization mass spectrometry
(SELDI-MS), these immunogenic spots were assigned to six proteins: Cu-Zn SOD, BCSP31, GroEL,
GroES, L7/L12 and DnaK [79]. To identify novel candidate proteins for the development of a safer and
efficient vaccine, immunoproteomics of the B. abortus 2308 cell envelope (CE) using antiserum from
bovine and a human patient infected with B. suis was carried out. Among the 163 identified proteins,
several new immunogenic proteins such as fumarate reductase flavoprotein subunit, cysteine synthase
A and F0F1-type ATP synthase α-subunit were found. The authors assumed that those proteins were
suitable candidates for developing vaccines against brucellosis in humans and bovines [80]. Thirty-two
immunogenic spots reacted with both human and bovine anti-Brucella sera. A lysate of the B. melitensis
M5 vaccine strain was tested against pooled bovine sera, and 88 immunoreactive protein spots were
detected and assigned to 61 proteins by MALDI—TOF MS, including elongation factor G, F0F1 ATP
synthase ß-subunit beta and OMP1. Only eight were virulence-related proteins [83]. A B. melitensis 16M
cell lysate tested against pooled human and goat antiserum produced 23, 33 and 11 immunoreactive
protein spots with sera of humans, goats or both, respectively. Two interesting riboflavin synthase
α chain (RS-α) and Loraine synthase (LS-2) proteins were detected using antisera obtained from
Brucella-infected humans and goats. Both proteins (rRS-α and rLS-2-) provided partial protection in
mice challenged with B. melitensis [82]. Sera from cattle experimentally infected with B. abortus 2308
revealed 18 immunogenic insoluble proteins. The spots were reactive against anti-Brucella antisera
but not towards negative sera and anti Y. enterocolitica sera [81]. It is worth mentioning that protein
expression profiles differ depending on host species, Brucella spp. and stage of infection. Routine
serodiagnosis fails to detect the stage of infection, but proteomic analysis shows time-course-dependent
B. abortus protein patterns when a subsequent set of sera is used [84].
Prominent immunogenic proteins show time course-dependent reactions. It was found that 13, 24
and 55 proteins of B. abortus 544 were found to be reactive at day 10, 30 and 60 post-infection when
tested with sera from experimentally infected mice in 2DE immunoblotting, respectively [84]. In the
same context, B. abortus 544 protein lysates have been tested with sera from B. abortus-infected cattle at
week 3, week 7 and week 10 post-infection. Thus, 134, 110 and 106 proteins were reactive, respectively,
and 55 antigens were predominant at all three-time points [16]. Therefore, including different Brucella
biovars and different sets of sera is essential to learn about the brucellae proteome and host immune
responses to promote the development of advanced diagnostics and novel vaccine candidates [16,84].
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Table 2. List of immunoproteomics studies on brucellae using different sets of anti-Brucella antisera












25 proteins of B. abortus and 20
proteins of B. melitensis
2D immunoblotting,







Eight proteins of B. abortus and





3 B. abortus 544 B. abortus-infectedcattle
134, 110 and 106 proteins were
recognized at 3, 7 and 10 weeks
of infection, and 55 common
antigens
2D immunoblotting,
MALDI—TOF MS 2015 [16]
4 B. abortus 544 Experimentallyinfected mice
13, 24 and 55 immunoreactive
proteins were detected at 10, 30
and 60 days post-infection,
respectively. MALDI identified
17 of the 67 proteins
2D immunoblotting,
MALDI—TOF MS 2014 [84]









MALDI—TOF MS 2012 [81]
6 B. melitensis 16 Mand Rev.1
Pooled human and
goat antisera
23, 33 and 11 proteins reacted




7 B. melitensis M5vaccine strain




spots assigned to 61 proteins.
12 are immunogenic, 8 are
virulence-related proteins
2D immunoblotting,
MALDI—TOF MS 2011 [83]




17 immunoreactive out of 383





9 B. abortus 2308
Bovines and
infected human
patients with B. suis
infection
42 and 23 immunogenic spots






10 B. ovis Ram naturallyinfected with B. ovis
82 reactive protein spots were





11 B. melitensis B115 Monoclonalantibodies (MAbs)
25 protein spots from 595






Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE); Surface-enhanced laser desorption/
ionization mass spectrometry (SELDI-MS); Liquid chromatography—mass spectrometry (LC—MS).
Immunoblotting of whole-cell protein extracts of B. abortus and B. melitensis field strains against field
sera collected from cattle, buffaloes, sheep and goats was performed with SDS-PAGE and Western blotting.
The results showed that Brucella appeared to express heat shock proteins, enzymes, binding proteins
and hypothetical proteins for their survival in the host during the early stage of infection [78]. When
2DE immunoblotting was used, 25 proteins of B. abortus and 20 proteins of B. melitensis were distinctly
immunoreactive. Some were host-specific and others crossed the host species barrier. Three proteins from
B. abortus (Dihydrodipicolinate synthase, glyceraldehyde-3-phosphate dehydrogenase, and lactate/malate
dehydrogenase), and additionally, the amino acid ABC transporter substrate-binding protein from
B. melitensis and fumarylacetoacetate hydrolase from both Brucella spp. were immunoreactive with the
sera of naturally infected cattle, buffaloes, sheep and goats. The identified proteins were supposed to be
used for the design of serological assays able to detect pan-Brucella, B. abortus- and B. melitensis-specific
antibodies [15]. In addition to the number of immunoreactive spots detected in each study, there were few
fainter signals on the Western blot membrane, which were not traceable on the Coomassie-stained 2DE
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gel. Some of the signals appeared fainter or even absent on the gel. This phenomenon might be caused
by the sensitivity limitation of the staining/visualization method. The proteins behind these weak signals
might explain the mechanism of host specificity and the molecular mechanism of intercellular survival.
Recently, several studies have been carried out to evaluate immunogenicity and protective
responses, as well as the application of immunogenic proteins in the diagnosis of brucellosis [14,85].
For instance, the purified rAdk and rSecB of B. abortus have been proposed to be potential candidates
for subunit vaccines [86]. However, it is important to consider that the protective responses observed
in the mice model may not reflect the same protection in natural hosts. The immunogenic properties of
BP26 and BLS proteins have been tested and proposed to be among the best candidates for serology [87].
However, some studies showed optimistic results, the potential use of protein antigens in diagnosis
and subunit vaccines under field conditions is very limited.
6. Summary and Perspective
Proteomic technologies are major post-genomic approaches used to understand the consequences
of regulatory processes on the protein composition of microbes. It has proven as a handy tool to
study the microbial physiology, gene expression and the interaction between bacteria and their host
cells. Since the beginning of the 21st century, proteomics technology has been applied to unravel
various enigmatic areas of Brucella research. The earliest works begun with the protein separation by
SDS-PAGE and 2DE, i.e., the manual and mechanical excision of protein spots and the identification
of proteins using MALDI—TOF MS. In recent years, LC- MS-based proteomics technology has been
developed and is widely applied in Brucella research. It is capable of identifying and quantifying higher
numbers of proteins. Immunoproteomics utilizing 2DE—Western blotting is one of the most common
tools implemented to identify antigens for serodiagnostics and the development of recombinant
vaccine candidates. In the last decade, the development of LPS-free and protein-based antigens for
serodiagnostics or vaccine design has attracted researchers worldwide and became a central target in
the Brucella research. Several cell surface proteins and intracellular components of different Brucella
spp. have been identified and classified as protective antigens. However, they most often provide
only weak immunogenic responses. Several databases have been developed to be used for the direct
identification and classification of brucellae. Now the technology is used in routine microbiological
work and is the first line diagnosis. The use of proteomics as a comprehensive biological approach
has contributed to rapid species identification and a better understanding of various aspects of the
life cycle of brucellae. However, the current knowledge on proteomes of Brucella is mostly based
on the examination of type strains or a limited number of isolates from a single host. This lack of
data results in a somewhat sketchy picture of the whole proteome of Brucella and needs to be closed
by pan-proteomics studies. Thus, the future of Brucella proteomics should focus on whole and pan
proteomes [12]. Comparative and comprehensive proteomics analysis of several types and wild
strains of brucellae from different host populations may help to discover crucial virulence proteins,
unravel the secrets behind host specificity and the host–pathogen interaction phenomena, as well
as to identify virulence mechanisms. This will also help to develop strategies to hinder spillover.
Several aspects of the biology of Brucella like host specificity, the interaction with the host immune
system, the development of resistance or intracellular survival are enigmatic. The use of proteomic
approaches has already contributed to unravel and elucidate some aspects of the pathogenesis of
Brucella. Proteome studies involving isolates of virulent and avirulent Brucella species and biovars in
combination with multitudes of infection models will enable us to develop better diagnostics and safer
vaccines in the future to combat brucellosis in humans and animals successfully.
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